Spiegel R

References (12)

Title : Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years - Small_2005_Int.J.Clin.Pract_59_473
Author(s) : Small GW , Kaufer D , Mendiondo MS , Quarg P , Spiegel R
Ref : Int J Clin Pract , 59 :473 , 2005
Abstract :
PubMedSearch : Small_2005_Int.J.Clin.Pract_59_473
PubMedID: 15853867

Title : Disease stage in Alzheimer disease and treatment effects of rivastigmine - Kurz_2004_Alzheimer.Dis.Assoc.Disord_18_123
Author(s) : Kurz A , Farlow M , Quarg P , Spiegel R
Ref : Alzheimer Disease & Associated Disorders , 18 :123 , 2004
Abstract :
PubMedSearch : Kurz_2004_Alzheimer.Dis.Assoc.Disord_18_123
PubMedID: 15494617

Title : Rivastigmine in Alzheimer disease: efficacy over two years - Grossberg_2004_Am.J.Geriatr.Psychiatry_12_420
Author(s) : Grossberg G , Irwin P , Satlin A , Mesenbrink P , Spiegel R
Ref : American Journal of Geriatry & Psychiatry , 12 :420 , 2004
Abstract :
PubMedSearch : Grossberg_2004_Am.J.Geriatr.Psychiatry_12_420
PubMedID: 15249280

Title : Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients - Almkvist_2004_Eur.J.Neurol_11_253
Author(s) : Almkvist O , Darreh-Shori T , Stefanova E , Spiegel R , Nordberg A
Ref : Eur Journal of Neurology , 11 :253 , 2004
Abstract :
PubMedSearch : Almkvist_2004_Eur.J.Neurol_11_253
PubMedID: 15061827

Title : Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease - Burns_2004_Int.J.Geriatr.Psychiatry_19_243
Author(s) : Burns A , Spiegel R , Quarg P
Ref : Int J Geriatr Psychiatry , 19 :243 , 2004
Abstract :
PubMedSearch : Burns_2004_Int.J.Geriatr.Psychiatry_19_243
PubMedID: 15027039

Title : [Rivastigmine: a review of its clinical effectiveness] - Spiegel_2002_Rev.Neurol_35_859
Author(s) : Spiegel R
Ref : Rev Neurol , 35 :859 , 2002
Abstract :
PubMedSearch : Spiegel_2002_Rev.Neurol_35_859
PubMedID: 12436385

Title : Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit - Giacobini_2002_J.Neural.Transm.(Vienna)_109_1053
Author(s) : Giacobini E , Spiegel R , Enz A , Veroff AE , Cutler NR
Ref : J Neural Transm (Vienna) , 109 :1053 , 2002
Abstract :
PubMedSearch : Giacobini_2002_J.Neural.Transm.(Vienna)_109_1053
PubMedID: 12111443

Title : Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study - McKeith_2000_Lancet_356_2031
Author(s) : McKeith I , Del Ser T , Spano P , Emre M , Wesnes K , Anand R , Cicin-Sain A , Ferrara R , Spiegel R
Ref : Lancet , 356 :2031 , 2000
Abstract :
PubMedSearch : McKeith_2000_Lancet_356_2031
PubMedID: 11145488

Title : Effects of the novel acetylcholinesterase inhibitor SDZ ENA 713 on sleep in man - Holsboer-Trachsler_1993_Neuropsychopharmacology_8_87
Author(s) : Holsboer-Trachsler E , Hatzinger M , Stohler R , Hemmeter U , Gray J , Muller J , Kocher R , Spiegel R
Ref : Neuropsychopharmacology , 8 :87 , 1993
Abstract :
PubMedSearch : Holsboer-Trachsler_1993_Neuropsychopharmacology_8_87
PubMedID: 8424849

Title : Pharmacologic and clinicopharmacologic properties of SDZ ENA 713, a centrally selective acetylcholinesterase inhibitor -
Author(s) : Enz A , Boddeke H , Gray J , Spiegel R
Ref : Annals of the New York Academy of Sciences , 640 :272 , 1991
PubMedID: 1776750

Title : Poster: Muscarinic agonists for senile dementia, past experience and future trends -
Author(s) : Gray JA , Enz A , Spiegel R
Ref : Trends in Pharmacological Sciences , Suppl :98 , 1989
PubMedID:

Title : Muscarinic agonists for senile dementia: past experience and future trends - Gray_1989_Trends.Pharmacol.Sci_Suppl_85
Author(s) : Gray JA , Enz A , Spiegel R
Ref : Trends in Pharmacological Sciences , Suppl :85 , 1989
Abstract :
PubMedSearch : Gray_1989_Trends.Pharmacol.Sci_Suppl_85
PubMedID: 2694530